Besides, FAT1 or its alterations were involved in inflammatory regulation in glioma31 and clinically influenced T-cell lymphoma outcome32, suggesting that FAT1 may be an immune response regulator and participate in distinct inflammatory processes. The gene discussed is FAT1; the disease is T-cell non-Hodgkin lymphoma.